Ocugen (OCGN) Tax Provisions (2021)
Ocugen (OCGN) reported Tax Provisions of -$52000.0 for Q3 2021.
Ocugen (OCGN) Tax Provisions (2021) Analysis & Trends
Ocugen has reported Tax Provisions for 1 years, with the latest figure at -$52000.0 in Q3 2021.
- For the quarter ending Q3 2021, Tax Provisions changed N/A year-over-year to -$52000.0; the trailing twelve-month figure through Dec 2022 stood at -$52000.0 (changed 0.0% YoY), and the FY2021 full-year result was -$52000.0, changed N/A from the prior year.
- Tax Provisions for Q3 2021 stood at -$52000.0.
- The five-year high for Tax Provisions was -$52000.0 in Q3 2021, with the low at -$52000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -52,000.00 |